CD21 Recombinant Antibody [PD00-23] - Rat IgG1 (Chimeric) - BSA and Azide free
Antibody Type
Recombinant Chimeric Antibody
Immunogen
Synthetic peptide within Human CD21 aa 1000 to the C-terminus.
Species Reactivity
Human
Validated Applications
WB, IHC-P
Target Molecular Weight
Predicted band size: 113 kDa
Conjugation
unconjugated
Clone Number
PD00-23
Reactivity Data
Tested Verified (internally validated)
Published Reported in literature (not internally validated)
Predicted Predicted reactive (based on sequence homology)
Not recommended Not recommended (failed internal validation)
WB
IHC-P
Human
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Lot Concentration Lookup
Storage Instructions
Store at 2-8℃. Avoid freeze.
Storage Buffer
PBS (pH7.4).
Purification Method
Protein A affinity purified.
Application Dilution
Target
Function
CD21 is a type I integral membrane glycoprotein that serves as a receptor for the C3d complement fragment and for the Epstein-Barr virus. It plays a role in B cell activation and proliferation and undergoes phosphorylation after B cell activation with phorbol esters. CD21 is expressed on mature B cells, follicular dendritic cells, pharyngeal and cervical epithelial cells and a subset of thymocytes. The adaptive immune response is tightly regulated to limit responding cells in an antigen-specific manner. On B cells, co-receptors CD21/CD19 modulate the strength of B cell Ag receptor (BCR) signals, thereby influencing cell fate. Complement receptor (CR) type 2 (CR2/ CD21) is normally expressed during the immature and mature stages of B cell development. In association with CD19, CD21 plays an important role in enhancing mature B cell responses to foreign antigens.
Background References
1. Smith NA. et. al. CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells. J Virol. 2020 May
2. Visentini M. et. al. CD21(low) B cells are predictive markers of new digital ulcers in systemic sclerosis. Clin Exp Immunol. 2021 Aug
This data was developed using HA601605, the same antibody clone in a different buffer formulation. Western blot analysis of CD21 on different lysates with Rabbit anti-CD21 antibody (HA601605) at 1/5,000 dilution.
Lane 1: Raji (Human Burkitt's lymphoma cells) Lane 2: K-562 (Human chronic myelogenous leukemia cells)
Lysates/proteins at 20 µg/Lane. Exposure time: 20 seconds; ECL: K1801
Negative expression of CD21 protein in K562 cell is consistent with the predicted expression pattern
Blocking: 5% NFDM/TBST, 1 hour at room temperature Primary antibody: HA601605, 1/5,000 in primary antibody dilution buffer (K1803), overnight at 4 ℃ Secondary antibody: Goat anti-Rat IgG-HRP (HA1023), 1/50,00 in 5% NFDM/TBST, 1 hour at room temperature
Predicted band size: 113 kDa Observed band size: 150 kDa
This data was developed using HA601605, the same antibody clone in a different buffer formulation. Application: Immunohistochemistry (IHC-P)
Species: Human
Tissue: Lymph node
Sample: Paraffin-embedded section